DAFTAR PUSTAKA

1. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes
Care. 2008;31:596-615.
2. Unger, Jeff. Diagnosis and Management of Type 2 Diabetes and Prediabetes. Chino
Medical Group, Diabetes and Headache Intervention Center. 2007. 731-759.
3. Perkumpulan Endokrinologi Indonesia. Konsensus: Pengelolaan dan Pencegahan
Diabetes Mellitus Tipe 2 di Indonesia. 2011.
4. Prediabetes. Januari 2008. http://www.mayoclinic.com [diakses tanggal 10 Maret 2014].
5. Alberty
G.
26
April
2007.
International
Diabetic
Federation.
http://www.idf.org/webcast/barcelona com. [diakses tanggal 10 Maret 2014].
6. Maitra A. The Endocrine System. In: Kumar V, Abbas AK, Fausto N, Mitchell RN.
Robbins Basic Pathology. 8th ed. China: Saunders Elsevier;2007. p.776-87.
7. Kieffer TJ, Habener JF. The glucagon-like peptides. Endocr Rev. 1999;20(6):876-913.
Available from:http://www.edrv. endojournals.org/cgi/reprint/876.
8. Druce MR, Small CJ, Bloom SR. Minireview: Gut peptides regu- lating satiety. Endocr.
2004;145:2660-65.

Available

from:

http:/

/www.endo.endojournals.org/cgi/reprint/14562660.
9. Anderson JW. Diabetes Mellitus: Medical nutrition therapy. Dalam: Shils ME, Shike M,
Ross AC, Caballero B, Cousins RJ, editor. Modern Nutrition in Health and Disease. Edisi
ke-10. Philadelphia: Lippincot Williams and Wilkins. 2006. hal.1043- 64.
10. Ahren B. Glukagon-Like Peptide-1 (GLP-1): A gut hormone of potential interest in the
treatment of diabetes. Bio Essay. 1998; 20:642-51.
11. Holst JJ. The physiology of glucagon-like peptide-1. Pysiol Rev 2007;87:1409-39.
Available from: http://physrev.physiology.org/ cgi/reprint/8741409.
12. Campbell RK. Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents
for the treatment of type 2 diabetes mellitus. Ann Pharmacother. 2007;41:51-60.
13. Waspadji S. Diabetes Melitus: Mekanisme dasar dan penge- lolaannya yang rasional.
Dalam: Soegondo S, Soewondo P, Subekti I, editor. Penatalaksanaan Diabetes Melitus
Terpadu. Edisi ke-2. Jakarta: Balai Penerbit FKUI. 2009.hal.31-45.
14. Ahren B, Holst JJ, Mari A. Characterization of GLP-1 effects on -cell function after
meal

ingestion

in

humans.

Diab

Care.

2003;26:2860-64.

Available

from:

http://www.care.diabetes-journals.org/content/26/10/2860.full.pdf.
15. American Diabetes Association. Standards of Medical Care in Diabetes-2013. Diabetes
care, Vol. 36, Suppl. I;2013.
16. Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan Departemen
Kesehatan Republik Indonesia Tahun 2008. Pedoman Pengendalian Diabetes Melitus dan
Penyakit Metabolik. Jakarta: Depkes RI;2008.p.1.

39

17. Powers AC. Diabetes Mellitus. In: Fauci AS, Kasper DL, Longo DL, Braunwald E,
Hauser SL, Jameson JL, et al. Harrisons Principles Internal Medicine. 17th ed. USA:
McGraw-Hill;2008.
18. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance
with high diabetes prevalence and cardiovascular risk in South Asians. Lancet
1991;337:382-386.

40